Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

115.52
+1.010.88%
Post-market: 115.850.3324+0.29%17:15 EDT
Volume:192.68K
Turnover:22.25M
Market Cap:1.04B
PE:93.60
High:116.46
Open:114.98
Low:114.98
Close:114.51
52wk High:118.00
52wk Low:85.91
Shares:8.99M
Float Shares:8.99M
Volume Ratio:0.57
T/O Rate:2.14%
Dividend:2.17
Dividend Rate:1.88%
EPS(TTM):1.23
EPS(LYR):0.7765
ROE:--
ROA:--
PB:--
PE(LYR):148.77

Loading ...

Eli Lilly: Foundayo NOW Available in UK to be Prescribed for Eligible Adults Via Private Prescription

THOMSON REUTERS
·
Aug 24

Eli Lilly: in UK, Foundayo is Priced Lower than Mounjaro; Likely to be in Order of £100 to £120

THOMSON REUTERS
·
Aug 24

Celltrion Seeks Korean Approval for Keytruda Biosimilar CT-P51 After Positive Trial

TIPRANKS
·
Aug 24

AMD Stock Joins Cash Flow Picks Trading Below Fair Value

Simply Wall St.
·
Aug 24

Hype for Moderna's Cancer Vaccine is Running Ahead of the Math - Heard on the Street

Dow Jones
·
Aug 23

Moderna (MRNA) Posts First Late Stage mRNA Cancer Vaccine Win In Melanoma

Simply Wall St.
·
Aug 23

Merck & Company Soars on Breakthrough Cancer Vaccine Hopes

TIPRANKS
·
Aug 22

Broadcom Stock Headlines 3 Cash Flow Picks Trading Below Fair Value

Simply Wall St.
·
Aug 22

Johnson & Johnson, AbbVie, Chevron, Energy Transfer, Home Depot Shaken

TIPRANKS
·
Aug 22

Moderna, ADI, Merck, EPR, TJX: Trending With Analysts

TIPRANKS
·
Aug 22

How a Big Bet on Cancer Vaccines Brought Moderna Back from the Brink

Dow Jones
·
Aug 22

Top Stock Market Highlights of the Week: Sembcorp Industries, Singapore’s Big Three Banks, Moderna and CapitaLand Investment

The Smart Investor
·
Aug 22

Novavax Inc. Stock Rises 6.2%, Outperforms Peers

Dow Jones
·
Aug 22

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 22

Goldman Sachs, Merck Share Gains Contribute to Dow's 500-Point Jump

Dow Jones
·
Aug 22

US Equity Indexes Lower This Week as Trump Threatens Major Economic War on Iran

MT Newswires Live
·
Aug 22

Merck Price Target Raised to $160.00/Share from $140.00 by Goldman Sachs

Dow Jones
·
Aug 22

AbbVie Expands Aesthetics Pipeline With New Phase 2 Forehead Lines Study

TIPRANKS
·
Aug 22

Eli Lilly Targets Ramadan Diabetes Market With New Orforglipron Trial

TIPRANKS
·
Aug 22

AbbVie Targets Pediatric Alopecia With New Phase 3 Trial: What Investors Should Watch

TIPRANKS
·
Aug 22